Miguel Angel López's doping ban appeal rejected by CAS

ALTO COLORADO ARGENTINA JANUARY 27 Miguel Angel Lopez of Colombia and Team Medellin EPM celebrates at finish line as stage winner during the 39th Vuelta a San Juan International 2023 Stage 5 a 1733km stage from Chimbas to Alto Colorado 2623m VueltaSJ2023 on January 27 2023 in Alto Colorado Argentina Photo by Maximiliano BlancoGetty Images
Miguel Angel López in action at the 2023 Vuelta a San Juan, which he won before he was stripped of the result (Image credit: Getty Images)

The Court of Arbitration for Sport (CAS) has rejected Miguel Angel López's appeal against a four-year doping ban handed to him last year.

The Colombian racer was given a retroactive ban by the UCI, dating from July 25, 2023, after being found guilty of 'use and possession of a prohibited substance, Menotropin' during the 2022 Giro d'Italia.

Dani Ostanek
Senior News Writer

Dani Ostanek is Senior News Writer at Cyclingnews, having joined in 2017 as a freelance contributor and later being hired full-time. Before joining the team, she had written for numerous major publications in the cycling world, including CyclingWeekly and Rouleur. She writes and edits at Cyclingnews as well as running newsletter, social media, and how to watch campaigns.

Dani has reported from the world's top races, including the Tour de France, Road World Championships, and the spring Classics. She has interviewed many of the sport's biggest stars, including Mathieu van der Poel, Demi Vollering, and Remco Evenepoel, and her favourite races are the Giro d'Italia, Strade Bianche and Paris-Roubaix.

Season highlights from 2024 include reporting from Paris-Roubaix –  'Unless I'm in an ambulance, I'm finishing this race' – Cyrus Monk, the last man home at Paris-Roubaix – and the Tour de France – 'Disbelief', gratitude, and family – Mark Cavendish celebrates a record-breaking Tour de France sprint win.

You must confirm your public display name before commenting

Please logout and then login again, you will then be prompted to enter your display name.